论文部分内容阅读
目的:对肺癌患者的临床特点和预后因素进行分析,同时探讨相关的治疗方法。方法:在2010年3月~2013年4月期间,总共收治了肺癌患者134例。对这些患者随机分成对照组和试验组,分别为67例患者;对照组:给患者使用斑蝥酸钠维生素B6注射液0.4mg+0.9%氯化钠注射液250ml进行静脉滴注,一直到患者的病情出现进展或患者对药物的副作用不能忍受为止;试验组:在对照组的基础上,给患者进行临终关怀治疗。对2组患者进行为期6个月的治疗,并对患者进行随访,对在临床上的治疗效果以及出现的不良反应进行评定和对比。结果:试验组治疗总有效率为85.1%明显高于对照组70.1%。差异显著,具有统计学意义(P<0.05)。预后因素主要有:患者是否吸烟和病理类型以及临床分期是否有合并症等。结论:对患者的临床特点进行分析和研究,对肺癌患者采用斑蝥酸钠维生素B6注射液联合临终关怀进行治疗,治疗效果显著,且安全性高,预后效果好
Objective: To analyze the clinical features and prognostic factors of patients with lung cancer and to explore the related treatment methods. Methods: From March 2010 to April 2013, a total of 134 patients with lung cancer were admitted. The patients were randomly divided into control group and experimental group, respectively, 67 patients; control group: patients with cantharidin sodium vitamin B6 injection 0.4ml + 0.9% sodium chloride injection 250ml intravenous infusion until the patient’s The progress of the disease or patients can not tolerate the side effects of drugs so far; experimental group: on the basis of the control group, to patients with hospice care. The two groups of patients for a period of 6 months of treatment, and patients were followed up on the clinical treatment and adverse reactions were assessed and compared. Results: The total effective rate of the experimental group was 85.1%, which was significantly higher than that of the control group (70.1%). The difference was significant, with statistical significance (P <0.05). Prognostic factors are: whether the patient is smoking and pathological types and clinical stage if there are complications and so on. Conclusion: The clinical features of patients were analyzed and studied. The treatment of patients with lung cancer using sodium cantharidate vitamin B6 injection combined with hospice care was significant, with high safety and good prognosis